Copy Number Variants Account for a Tiny Fraction of Undiagnosed Myopathic Patients

T. Giugliano, M. Savarese, A. Garofalo, E. Picillo, C. Fiorillo, A. D'Amico, L. Maggi, L. Ruggiero, L. Vercelli, F. Magri, F. Fattori, A. Torella, M. Ergoli, A. Rubegni, M. Fanin, O. Musumeci, J. Bleecker, L. Peverelli, M. Moggio, E. MercuriA. Toscano, M. Mora, L. Santoro, T. Mongini, E. Bertini, C. Bruno, C. Minetti, G. P. Comi, F. M. Santorelli, C. Angelini, L. Politano, G. Piluso, V. Nigro

Research output: Contribution to journalArticle

Abstract

Next-generation sequencing (NGS) technologies have led to an increase in the diagnosis of heterogeneous genetic conditions. However, over 50% of patients with a genetically inherited disease are still without a diagnosis. In these cases, different hypotheses are usually postulated, including variants in novel genes or elusive mutations. Although the impact of copy number variants (CNVs) in neuromuscular disorders has been largely ignored to date, missed CNVs are predicted to have a major role in disease causation as some very large genes, such as the dystrophin gene, have prone-to-deletion regions. Since muscle tissues express several large disease genes, the presence of elusive CNVs needs to be comprehensively assessed following an accurate and systematic approach. In this multicenter cohort study, we analyzed 234 undiagnosed myopathy patients using a custom array comparative genomic hybridization (CGH) that covers all muscle disease genes at high resolution. Twenty-two patients (9.4%) showed non-polymorphic CNVs. In 12 patients (5.1%), the identified CNVs were considered responsible for the observed phenotype. An additional ten patients (4.3%) presented candidate CNVs not yet proven to be causative. Our study indicates that deletions and duplications may account for 5(-)9% of genetically unsolved patients. This strongly suggests that other mechanisms of disease are yet to be discovered.
Original languageEnglish
Pages (from-to)10.3390/genes9110524
JournalGenes
Volume9
Issue number11
DOIs
Publication statusPublished - Oct 26 2018

Fingerprint

Genes
Muscles
Dystrophin
Comparative Genomic Hybridization
Muscular Diseases
Causality
Multicenter Studies
Cohort Studies
Technology
Phenotype
Mutation

Cite this

Giugliano, T., Savarese, M., Garofalo, A., Picillo, E., Fiorillo, C., D'Amico, A., ... Nigro, V. (2018). Copy Number Variants Account for a Tiny Fraction of Undiagnosed Myopathic Patients. Genes, 9(11), 10.3390/genes9110524. https://doi.org/E524 [pii]

Copy Number Variants Account for a Tiny Fraction of Undiagnosed Myopathic Patients. / Giugliano, T.; Savarese, M.; Garofalo, A.; Picillo, E.; Fiorillo, C.; D'Amico, A.; Maggi, L.; Ruggiero, L.; Vercelli, L.; Magri, F.; Fattori, F.; Torella, A.; Ergoli, M.; Rubegni, A.; Fanin, M.; Musumeci, O.; Bleecker, J.; Peverelli, L.; Moggio, M.; Mercuri, E.; Toscano, A.; Mora, M.; Santoro, L.; Mongini, T.; Bertini, E.; Bruno, C.; Minetti, C.; Comi, G. P.; Santorelli, F. M.; Angelini, C.; Politano, L.; Piluso, G.; Nigro, V.

In: Genes, Vol. 9, No. 11, 26.10.2018, p. 10.3390/genes9110524.

Research output: Contribution to journalArticle

Giugliano, T, Savarese, M, Garofalo, A, Picillo, E, Fiorillo, C, D'Amico, A, Maggi, L, Ruggiero, L, Vercelli, L, Magri, F, Fattori, F, Torella, A, Ergoli, M, Rubegni, A, Fanin, M, Musumeci, O, Bleecker, J, Peverelli, L, Moggio, M, Mercuri, E, Toscano, A, Mora, M, Santoro, L, Mongini, T, Bertini, E, Bruno, C, Minetti, C, Comi, GP, Santorelli, FM, Angelini, C, Politano, L, Piluso, G & Nigro, V 2018, 'Copy Number Variants Account for a Tiny Fraction of Undiagnosed Myopathic Patients', Genes, vol. 9, no. 11, pp. 10.3390/genes9110524. https://doi.org/E524 [pii]
Giugliano T, Savarese M, Garofalo A, Picillo E, Fiorillo C, D'Amico A et al. Copy Number Variants Account for a Tiny Fraction of Undiagnosed Myopathic Patients. Genes. 2018 Oct 26;9(11):10.3390/genes9110524. https://doi.org/E524 [pii]
Giugliano, T. ; Savarese, M. ; Garofalo, A. ; Picillo, E. ; Fiorillo, C. ; D'Amico, A. ; Maggi, L. ; Ruggiero, L. ; Vercelli, L. ; Magri, F. ; Fattori, F. ; Torella, A. ; Ergoli, M. ; Rubegni, A. ; Fanin, M. ; Musumeci, O. ; Bleecker, J. ; Peverelli, L. ; Moggio, M. ; Mercuri, E. ; Toscano, A. ; Mora, M. ; Santoro, L. ; Mongini, T. ; Bertini, E. ; Bruno, C. ; Minetti, C. ; Comi, G. P. ; Santorelli, F. M. ; Angelini, C. ; Politano, L. ; Piluso, G. ; Nigro, V. / Copy Number Variants Account for a Tiny Fraction of Undiagnosed Myopathic Patients. In: Genes. 2018 ; Vol. 9, No. 11. pp. 10.3390/genes9110524.
@article{07316a45782f45b6a798e477792b030c,
title = "Copy Number Variants Account for a Tiny Fraction of Undiagnosed Myopathic Patients",
abstract = "Next-generation sequencing (NGS) technologies have led to an increase in the diagnosis of heterogeneous genetic conditions. However, over 50{\%} of patients with a genetically inherited disease are still without a diagnosis. In these cases, different hypotheses are usually postulated, including variants in novel genes or elusive mutations. Although the impact of copy number variants (CNVs) in neuromuscular disorders has been largely ignored to date, missed CNVs are predicted to have a major role in disease causation as some very large genes, such as the dystrophin gene, have prone-to-deletion regions. Since muscle tissues express several large disease genes, the presence of elusive CNVs needs to be comprehensively assessed following an accurate and systematic approach. In this multicenter cohort study, we analyzed 234 undiagnosed myopathy patients using a custom array comparative genomic hybridization (CGH) that covers all muscle disease genes at high resolution. Twenty-two patients (9.4{\%}) showed non-polymorphic CNVs. In 12 patients (5.1{\%}), the identified CNVs were considered responsible for the observed phenotype. An additional ten patients (4.3{\%}) presented candidate CNVs not yet proven to be causative. Our study indicates that deletions and duplications may account for 5(-)9{\%} of genetically unsolved patients. This strongly suggests that other mechanisms of disease are yet to be discovered.",
author = "T. Giugliano and M. Savarese and A. Garofalo and E. Picillo and C. Fiorillo and A. D'Amico and L. Maggi and L. Ruggiero and L. Vercelli and F. Magri and F. Fattori and A. Torella and M. Ergoli and A. Rubegni and M. Fanin and O. Musumeci and J. Bleecker and L. Peverelli and M. Moggio and E. Mercuri and A. Toscano and M. Mora and L. Santoro and T. Mongini and E. Bertini and C. Bruno and C. Minetti and Comi, {G. P.} and Santorelli, {F. M.} and C. Angelini and L. Politano and G. Piluso and V. Nigro",
note = "LR: 20181217; GR: TGM11Z06/Fondazione Telethon; GR: GUP10006/Telethon UILDM; GR: GUP11006/Telethon UILDM; JID: 101551097; OTO: NOTNLM; 2018/09/14 00:00 [received]; 2018/10/19 00:00 [revised]; 2018/10/23 00:00 [accepted]; 2018/10/31 06:00 [entrez]; 2018/10/31 06:00 [pubmed]; 2018/10/31 06:01 [medline]; epublish",
year = "2018",
month = "10",
day = "26",
doi = "E524 [pii]",
language = "English",
volume = "9",
pages = "10.3390/genes9110524",
journal = "Genes",
issn = "2073-4425",
publisher = "MDPI AG",
number = "11",

}

TY - JOUR

T1 - Copy Number Variants Account for a Tiny Fraction of Undiagnosed Myopathic Patients

AU - Giugliano, T.

AU - Savarese, M.

AU - Garofalo, A.

AU - Picillo, E.

AU - Fiorillo, C.

AU - D'Amico, A.

AU - Maggi, L.

AU - Ruggiero, L.

AU - Vercelli, L.

AU - Magri, F.

AU - Fattori, F.

AU - Torella, A.

AU - Ergoli, M.

AU - Rubegni, A.

AU - Fanin, M.

AU - Musumeci, O.

AU - Bleecker, J.

AU - Peverelli, L.

AU - Moggio, M.

AU - Mercuri, E.

AU - Toscano, A.

AU - Mora, M.

AU - Santoro, L.

AU - Mongini, T.

AU - Bertini, E.

AU - Bruno, C.

AU - Minetti, C.

AU - Comi, G. P.

AU - Santorelli, F. M.

AU - Angelini, C.

AU - Politano, L.

AU - Piluso, G.

AU - Nigro, V.

N1 - LR: 20181217; GR: TGM11Z06/Fondazione Telethon; GR: GUP10006/Telethon UILDM; GR: GUP11006/Telethon UILDM; JID: 101551097; OTO: NOTNLM; 2018/09/14 00:00 [received]; 2018/10/19 00:00 [revised]; 2018/10/23 00:00 [accepted]; 2018/10/31 06:00 [entrez]; 2018/10/31 06:00 [pubmed]; 2018/10/31 06:01 [medline]; epublish

PY - 2018/10/26

Y1 - 2018/10/26

N2 - Next-generation sequencing (NGS) technologies have led to an increase in the diagnosis of heterogeneous genetic conditions. However, over 50% of patients with a genetically inherited disease are still without a diagnosis. In these cases, different hypotheses are usually postulated, including variants in novel genes or elusive mutations. Although the impact of copy number variants (CNVs) in neuromuscular disorders has been largely ignored to date, missed CNVs are predicted to have a major role in disease causation as some very large genes, such as the dystrophin gene, have prone-to-deletion regions. Since muscle tissues express several large disease genes, the presence of elusive CNVs needs to be comprehensively assessed following an accurate and systematic approach. In this multicenter cohort study, we analyzed 234 undiagnosed myopathy patients using a custom array comparative genomic hybridization (CGH) that covers all muscle disease genes at high resolution. Twenty-two patients (9.4%) showed non-polymorphic CNVs. In 12 patients (5.1%), the identified CNVs were considered responsible for the observed phenotype. An additional ten patients (4.3%) presented candidate CNVs not yet proven to be causative. Our study indicates that deletions and duplications may account for 5(-)9% of genetically unsolved patients. This strongly suggests that other mechanisms of disease are yet to be discovered.

AB - Next-generation sequencing (NGS) technologies have led to an increase in the diagnosis of heterogeneous genetic conditions. However, over 50% of patients with a genetically inherited disease are still without a diagnosis. In these cases, different hypotheses are usually postulated, including variants in novel genes or elusive mutations. Although the impact of copy number variants (CNVs) in neuromuscular disorders has been largely ignored to date, missed CNVs are predicted to have a major role in disease causation as some very large genes, such as the dystrophin gene, have prone-to-deletion regions. Since muscle tissues express several large disease genes, the presence of elusive CNVs needs to be comprehensively assessed following an accurate and systematic approach. In this multicenter cohort study, we analyzed 234 undiagnosed myopathy patients using a custom array comparative genomic hybridization (CGH) that covers all muscle disease genes at high resolution. Twenty-two patients (9.4%) showed non-polymorphic CNVs. In 12 patients (5.1%), the identified CNVs were considered responsible for the observed phenotype. An additional ten patients (4.3%) presented candidate CNVs not yet proven to be causative. Our study indicates that deletions and duplications may account for 5(-)9% of genetically unsolved patients. This strongly suggests that other mechanisms of disease are yet to be discovered.

U2 - E524 [pii]

DO - E524 [pii]

M3 - Article

VL - 9

SP - 10.3390/genes9110524

JO - Genes

JF - Genes

SN - 2073-4425

IS - 11

ER -